Product Wiki · Recalls · EU Safety Gate (RAPEX)

Butapren — recall A12/01969/24

EU Safety Gate (RAPEX) · Lithuania · 2024-08-02 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/01969/24
Date of alert
2024-08-02
Country / jurisdiction
Lithuania
Risk level
Serious risk
Risk type
Chemical
Product category
Chemical products
Product type
Glue
Barcode (EAN/GTIN)
5906197589043
Reported risk: Produkte yra per didelė tolueno koncentracija (išmatuota vertė 57 % masės). Toluenas yra neurotoksiškas, jei įkvepiamas arba susilietus su oda, ir gali paveikti negimusį vaiką. Produktas neatitinka REACH reglamento.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Retailer
Category of measure
Withdrawal of the product from the market
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Butapren

Risk Description (original English): The product has an excessive concentration of toluene (measured value 57 % by weight). Toluene is neurotoxic, if inhaled or in contact with the skin, and might also affect the unborn child.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10013920

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.